Johnson & Johnson: all 3,718 studies

Page 25 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• The V-Wave Shunt: FIM Safety and Feasibility StudyCompletedNCT01965015Not applicable
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male ParticipantsCompletedNCT01964872Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly ParticipantsCompletedNCT01964651Phase 1
• Clinical Assessment and Psychosocial Impact of PsoriasisCompletedNCT01964443
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or LymphomaCompletedNCT01962532Phase 1
• A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT01959282Phase 2
• A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male PatientsCompletedNCT01951053Phase 1
• A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male ParticipantsCompletedNCT01949610Phase 1
• A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy VolunteersCompletedNCT01947920Phase 1
• A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With SchizophreniaCompletedNCT01947803Phase 4
• A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With SchizophreniaCompletedNCT01942382Phase 1
• A Post-Approval Study of the LINX® Reflux Management SystemCompletedNCT01940185
• Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza ChallengeCompletedNCT01938352Phase 2
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-40411813 in Male and Female Elderly PatientsCompletedNCT01932333Phase 1
• A Study to Evaluate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813CompletedNCT01932320Phase 1
• A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy VolunteersCompletedNCT01928316Phase 1
• A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital SettingCompletedNCT01926912
• A Non-drug Study Profiling Cutaneous LupusCompletedNCT01923415
• A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and UnijectCompletedNCT01917357Phase 3
• Study to Evaluate Optimized Retreatment and Prolonged Therapy With BortezomibCompletedNCT01910987Phase 3
• An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01909427Phase 2
• An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of MetoclopramideCompletedNCT01907633
• Study of Single and Multiple Doses of ALS-008176 in Healthy VolunteersCompletedNCT01906164Phase 1
• An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular LymphomaTerminatedNCT01902862Phase 2
• A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy ParticipantsWithdrawnNCT01902550Phase 1
• An Observational Study to Evaluate the Quality of Life in Korean Female Participants With Chronic ConstipationCompletedNCT01902537
• Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic PainCompletedNCT01902524Phase 4
• A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) TabletCompletedNCT01900587Phase 1
• A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT01900574Phase 1
• A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male ParticipantsCompletedNCT01897389Phase 1
• Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)CompletedNCT01893177Phase 3
• A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy VolunteersCompletedNCT01891851Phase 1
• Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT01888107Phase 3
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly ParticipantsCompletedNCT01887535Phase 1
• ASR-XL Metal-on-Metal 522 Post-Market Surveillance StudyCompletedNCT01884532
• An Observational Study of Oral Fluoroquinolones and the Risk of Retinal DetachmentCompletedNCT01881438
• A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of HemorrhoidsCompletedNCT01881282Phase 4
• A Study to Assess Different Diagnostic Criteria of Chronic Constipation in AsiaCompletedNCT01880294
• Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in ChinaCompletedNCT01878981
• A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy VolunteersCompletedNCT01877889Phase 1
• Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy ParticipantsCompletedNCT01877226Phase 1
• Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / LumefantrineCompletedNCT01876966Phase 1
• A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male ParticipantsCompletedNCT01873001Phase 1
• An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01867762Phase 2
• A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy ParticipantsCompletedNCT01866033Phase 1
• A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy ParticipantsCompletedNCT01866007Phase 1
• A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic FunctionCompletedNCT01863784Phase 1
• A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyTerminatedNCT01862224Phase 2
• Occipital Nerve Stimulation in the Treatment of MigraineTerminatedNCT01855672Phase 1
• Study on the Treatment of Osteoporotic Vertebral Fractures Using Vertebral Body StentingCompletedNCT01847898Phase 4
• A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV InfectionCompletedNCT01846832Phase 3
• A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar PustulosisCompletedNCT01845987Phase 2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male ParticipantsCompletedNCT01840501Phase 1
• Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza PatientsCompletedNCT01839760
• A Study of Prophylaxis for Migraine Patients With Topiramate in IndiaCompletedNCT01836874
• A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerNo longer availableNCT01834209
• An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell LymphomaApproved for marketingNCT01833039
• The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain ManagementCompletedNCT01829828
• An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCompletedNCT01828879Phase 4
• Pinnacle Metal-on-Metal 522 Post-Market Surveillance StudyCompletedNCT01828801
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With PlaceboCompletedNCT01827982Phase 1
• The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male VolunteersCompletedNCT01826786Phase 1
• A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With CancerCompletedNCT01824524Phase 1
• A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent AsthmaCompletedNCT01823016Phase 2
• 14C-ARN-509 Microtracer Label AME and Absolute BA StudyCompletedNCT01822041Phase 1
• Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®CompletedNCT01822028Phase 1
• A Clinical Trial to Test the Effect of an Experimental Mouth Rinse on Gum DiseaseWithdrawnNCT01821261Not applicable
• A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy VolunteersCompletedNCT01821027Phase 1
• A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765CompletedNCT01820936Phase 1
• A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic PatientsCompletedNCT01819818
• A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and AcetaminophenCompletedNCT01819805
• Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational StudyCompletedNCT01816503
• A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT01815294Phase 1
• An Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of JNJ-17299425 in Participants With Traumatic Brain InjuryTerminatedNCT01814982Phase 2
• An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety SymptomsCompletedNCT01814098Phase 4
• A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCompletedNCT01814085Phase 4
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729CompletedNCT01813084Phase 1
• A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable SchizophreniaCompletedNCT01812642Phase 2
• A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese ParticipantsCompletedNCT01810887Phase 4
• To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian ParticipantsCompletedNCT01809353Phase 1
• The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With DepressionTerminatedNCT01809340Phase 2
• Powered Echelon Device in VATS SurgeryCompletedNCT01808430
• A Long-term Extension Study of PCI-32765 (Ibrutinib)Active, not recruitingNCT01804686Phase 3
• A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese ParticipantsCompletedNCT01804244Phase 4
• A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile DysfunctionTerminatedNCT01802359
• A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy ParticipantsCompletedNCT01800682Phase 1
• A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435CompletedNCT01799603Phase 1
• A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor AutoantibodiesWithdrawnNCT01798745Phase 2
• A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male PatientsCompletedNCT01798628Phase 1
• A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelCompletedNCT01795703Phase 2
• OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in ChinaCompletedNCT01795625
• Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone AcetateCompletedNCT01792687Phase 1
• A Study to Investigate the Absorption, Metabolism, and Excretion of Canagliflozin (JNJ-28431754) in Healthy Male VolunteersCompletedNCT01791231Phase 1
• A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01790100Phase 2
• A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy VolunteersCompletedNCT01788436Early Phase 1
• A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)CompletedNCT01787357Phase 1
• An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCompletedNCT01782729Phase 4
• A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy ParticipantsCompletedNCT01780259Phase 1
• A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular LymphomaCompletedNCT01779791Phase 2
• A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted ConditionCompletedNCT01778075Phase 1

← Johnson & Johnson overview and focus areas